Lisa Pierre

Lisa joins Sitryx from the Lung Cancer Initiative at Johnson and Johnson where, as Senior Director, she was responsible for driving the strategic and scientific direction of cross-sector (Pharm and MedTech), multidisciplinary development teams focused on the interception and treatment of lung cancer. Her previous roles include Senior Director, Clinical Development and Project Leader at RespiVert, a small, inhaled medicines company successfully delivering early clinical projects focused on treatments for respiratory diseases such as COPD and severe asthma, Early Development Lead in Immunology Translational Medicine at Janssen and Director of Clinical Research at the Merck Translational Medicines Research Centre in Singapore. Prior to that Lisa spent 10 years in roles of increasing responsibility at GlaxoSmithKline within Clinical Pharmacology and Discovery Medicine specialising in respiratory diseases. Lisa holds a first class honours degree in Pharmacology from King’s College, London and a Ph.D. in Pharmacology from University of Cambridge, UK.